Pidilite Inds. Q2 FY27 Earnings Call — Analysis (NSE: PIDILITIND)

Pidilite delivered 10.7% underlying volume growth and 21.7% revenue growth in Q2 FY27 despite severe VAM cost inflation, guiding for EBITDA margins to rebound toward the higher end of its 20–24% band in H2 following October price hikes.

5 Nov 2026 · Analysis by Alpha Inflection

Result quality: watch — Margin pressure. Management sentiment: optimistic.

The take

Q2FY27 International Subsidiaries Revenue Grow… 21.8% ( +21.8% YoY ) . Guidance cut — Q3FY27 price increases for high-inflat… 3% to 5% . New story: Proactive pricing offsets cost inflation .

Results

Standalone revenue grew 21.7% YoY with 10.7% underlying volume growth, while standalone EBITDA margin contracted 430 bps YoY to 20.4% due to peak VAM consumption costs of $1,630/t.

Financial highlights

Guidance

Management guided for H2 FY27 EBITDA margins to settle in the higher end of its 20–24% corridor supported by 3–5% price hikes implemented on October 1.

What management committed to

• [Management is] now again going to take 3% to 5% price increase in some of these areas where there is very heightened inflation. — 3% to 5%, Q3FY27
• [Pidilite is] very confident of Q3 and quite confident of the full second half that [Pidilite] should be able to deliver in [its] EBITDA margin corridor of 20% to 24%, ideally in the slightly higher end of the corridor. — 20-24%, ideally higher end (>22%), H2FY27
• [Pidilite's] desire over a period of time is to take underlying volume growth from classic double digit to early teens. — early teens, over a period of time

Key themes

Volume momentum and margin defense

How the narrative shifted

• Proactive pricing offsets cost inflation: The rebate and re-hike cycle was explained in detail, reframing in-quarter margin volatility as a deliberate demand-management tactic rather than an erosion of pricing power.
• Strong construction demand: Urban demand recovery was highlighted as a new positive driver, broadening the demand thesis beyond the previously dominant rural resilience.
• Geopolitical export headwinds: No improvement was noted; the headwind was explicitly acknowledged as ongoing with no recovery timeline offered.
• Growth categories gaining market share: The projects business was given a separate detailed segment-based strategy update, adding a new, more mature execution layer to the growth story beyond the retail channel.
• Innovation pipeline as moat: The call provided a more extensive catalog of innovations, explicitly framing them as fundamental shifts with large TAM potential (e.g., Grupopuma renders for exteriors).
• Margin resilience via operating leverage: The quarter's margin outcome was framed as a managed consequence of extreme VAM volatility and the strategic choice to rebate pricing; H1 margins (23.5%) were highlighted as a truer reflection of the company's earning power.
• Raw material cost volatility management: Transformed from a secondary factor in the prior call to a core narrative thread explaining the quarter's margin performance and the rationale behind every major pricing and strategy decision.
• Urban demand resurgence: Provides a new positive narrative to offset concerns about macro headwinds, showing that the company's customer base is not solely dependent on rural resilience.
• AI-driven operational efficiency: This is a new, concrete initiative thread, framed as a medium-term enabler of operating leverage rather than an immediate cost-cutting driver.

Operational commentary

• Implemented a 3–5% price increase across inflation-hit product lines on October 1, 2026, following a 12–15% increase executed across Q1 FY27.
• National rollout of Fevicol Multi Lock and Fevicol X-Per scheduled for November 2026 after successful pilot programs.
• Piloting new feature-led products including M-Seal Advance (universal, easy wash-off, low VOC) and Dr. Fixit Wonderproof.
• Expanded Araldite portfolio into premium niches with Araldite Wud-X, Stone-X, and White-X.
• Restructured Pidilite Projects Group (PPG) into dedicated end-user segments (residential/commercial builders, hotels/hospitals/institutions, EPC contractors), yielding early conversion gains in Q2.
• Grupopuma JV exterior renders (UnoFin) completed 6–7 pilot projects in North India; management is evaluating setting up additional manufacturing beyond the existing Rajasthan plant.
• Management explicitly ruled out backward integration into VAM, citing lack of scale benefits and unfavorable domestic economics for ethylene and acetic acid.

Analyst Q&A

• Q. Clarification on margin dynamics, pricing lag, and the current spot level of VAM and crude-linked inputs.

  Management explained that VAM was rebated in early Q2 when spot fell near $900-$1,000, but rose later in the quarter; pricing of 3–5% was executed on October 1. Current VAM is ~$1,200/t, giving confidence in delivering higher-end 20–24% EBITDA margins in H2.

• Q. Competitive intensity from local and regional players amid raw material hyperinflation.

  Unlike FMCG/laundry, Pidilite's direct competition in Dr. Fixit and tile adhesives consists of large organized companies rather than unorganized local players, keeping competitive intensity broadly unchanged.

• Q. Rationale regarding competitor backward integration into VAM manufacturing and whether Pidilite would consider building a plant.

  Pidilite evaluated VAM manufacturing and concluded India lacks competitive ethylene/acetic acid feedstocks; suboptimal-scale domestic plants offer no cost advantage over procurement, while supply security has never been compromised.

• Q. Progress on Grupopuma JV external renders (UnoFin) across northern markets.

  Good traction achieved across 6–7 pilot projects with architects in North India; business is focused on commercial, hotel, and low-rise residential projects, and management is evaluating adding capacity beyond Rajasthan.

View source

Research and educational content only. Not investment advice.